2-151525265-G-C
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001164507.2(NEB):c.22170C>G(p.Tyr7390*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000248 in 1,610,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001164507.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152126Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.00000804 AC: 2AN: 248796 AF XY: 0.00000741 show subpopulations
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1458262Hom.: 0 Cov.: 30 AF XY: 0.00000276 AC XY: 2AN XY: 725674 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152126Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 74314 show subpopulations
ClinVar
Submissions by phenotype
Nemaline myopathy 2 Pathogenic:2
This sequence change creates a premature translational stop signal (p.Tyr7425*) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). This variant is present in population databases (rs748922882, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with nemaline myopathy (PMID: 12207938, 16917880). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as p.Tyr5689*. ClinVar contains an entry for this variant (Variation ID: 578209). For these reasons, this variant has been classified as Pathogenic.
The heterozygous p.Tyr7425Ter variant in NEB was identified, in the compound heterozygous state with a likely pathogenic variant (ClinVar Variation ID: 1458230), in one individual with nemaline myopathy. This individual also carried a likely pathogenic variant (ClinVar Variation ID: 1458230), however, the phase of these variants are unknown at this time. The p.Tyr7425Ter variant in NEB has been previously reported in 4 unrelated individuals with nemaline myopathy (PMID: 36233295, PMID: 16917880, PMID: 12207938, PMID: 25205138) but has been identified in 0.006% (2/34488) of Latino/Admixed American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs748922882). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. Of these 4 unrelated individuals, 3 were compound heterozygotes who carried pathogenic or likely pathogenic variants in trans (PMID: 16917880, PMID: 25205138, ClinVar Variation ID: 1458230; PMID: 36233295, ClinVar Variation ID: 521691), which increases the likelihood that the p.Tyr7425Ter variant is pathogenic. This variant has also been reported in ClinVar (Variation ID: 578209) and has been interpreted as pathogenic by Fulgent Genetics and Invitae and as likely pathogenic by Women's Health and Genetics/Laboratory Corporation of America, LabCorp. This nonsense variant leads to a premature termination codon at position 7425, which is predicted to lead to a truncated or absent protein. Loss of function of the NEB gene is an established disease mechanism in autosomal recessive nemaline myopathy 2. In summary, this variant meets criteria to be classified as pathogenic for nemaline myopathy 2. ACMG/AMP Criteria applied: PVS1, PM2_Supporting, PM3_Strong (Richards 2015).
Nemaline myopathy Pathogenic:1
Variant summary: NEB c.22275C>G (p.Tyr7425X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. c.24407_24410dupTGTT (p.Leu8137fsX18), c.24559C>T (p.Arg8187X), and c.24632_24633delCT (p.Pro8211fsX4)). The variant allele was found at a frequency of 8.1e-06 in 245950 control chromosomes (gnomAD). The variant, c.22275C>G, has been reported in the literature in an individual affected with Nemaline Myopathy 2 (Pelin_2002). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) cites the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 31589614, 16917880, 12207938, 36714460, 36233295)
Arthrogryposis multiplex congenita 6 Pathogenic:1
Nemaline myopathy 2;C5543431:Arthrogryposis multiplex congenita 6 Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at